These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 31881785)

  • 1. The Significance of Halogen Bonding in Ligand-Receptor Interactions: The Lesson Learned from Molecular Dynamic Simulations of the D
    Kurczab R; Kucwaj-Brysz K; Śliwa P
    Molecules; 2019 Dec; 25(1):. PubMed ID: 31881785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amino Acid Hot Spots of Halogen Bonding: A Combined Theoretical and Experimental Case Study of the 5-HT
    Kurczab R; Canale V; Satała G; Zajdel P; Bojarski AJ
    J Med Chem; 2018 Oct; 61(19):8717-8733. PubMed ID: 30188719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Halogen bonding in ligand-receptor systems in the framework of classical force fields.
    Rendine S; Pieraccini S; Forni A; Sironi M
    Phys Chem Chem Phys; 2011 Nov; 13(43):19508-16. PubMed ID: 21964576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Halogen Bonding in Haspin-Halogenated Tubercidin Complexes: Molecular Dynamics and Quantum Chemical Calculations.
    Zhou Y; Wong MW
    Molecules; 2022 Jan; 27(3):. PubMed ID: 35163974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A quantum mechanics-based halogen bonding scoring function for protein-ligand interactions.
    Yang Z; Liu Y; Chen Z; Xu Z; Shi J; Chen K; Zhu W
    J Mol Model; 2015 Jun; 21(6):138. PubMed ID: 25957658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Halogen bonding in halocarbon-protein complexes and computational tools for rational drug design.
    Costa PJ; Nunes R; Vila-Viçosa D
    Expert Opin Drug Discov; 2019 Aug; 14(8):805-820. PubMed ID: 31131651
    [No Abstract]   [Full Text] [Related]  

  • 7. Do Halogen-Hydrogen Bond Donor Interactions Dominate the Favorable Contribution of Halogens to Ligand-Protein Binding?
    Lin FY; MacKerell AD
    J Phys Chem B; 2017 Jul; 121(28):6813-6821. PubMed ID: 28657759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Halogen bonding for rational drug design and new drug discovery.
    Lu Y; Liu Y; Xu Z; Li H; Liu H; Zhu W
    Expert Opin Drug Discov; 2012 May; 7(5):375-83. PubMed ID: 22462734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Principles and applications of halogen bonding in medicinal chemistry and chemical biology.
    Wilcken R; Zimmermann MO; Lange A; Joerger AC; Boeckler FM
    J Med Chem; 2013 Feb; 56(4):1363-88. PubMed ID: 23145854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Halogen Bonds in Ligand-Protein Systems: Molecular Orbital Theory for Drug Design.
    Margiotta E; van der Lubbe SCC; de Azevedo Santos L; Paragi G; Moro S; Bickelhaupt FM; Fonseca Guerra C
    J Chem Inf Model; 2020 Mar; 60(3):1317-1328. PubMed ID: 32003997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 3D-QSAR based on quantum-chemical molecular fields: toward an improved description of halogen interactions.
    Güssregen S; Matter H; Hessler G; Müller M; Schmidt F; Clark T
    J Chem Inf Model; 2012 Sep; 52(9):2441-53. PubMed ID: 22917472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular dynamics simulation of halogen bonding mimics experimental data for cathepsin L inhibition.
    Celis-Barros C; Saavedra-Rivas L; Salgado JC; Cassels BK; Zapata-Torres G
    J Comput Aided Mol Des; 2015 Jan; 29(1):37-46. PubMed ID: 25338130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Halogen bonding at the ATP binding site of protein kinases: preferred geometry and topology of ligand binding.
    Poznański J; Shugar D
    Biochim Biophys Acta; 2013 Jul; 1834(7):1381-6. PubMed ID: 23376187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rediscovery of halogen bonds in protein-ligand complexes.
    Zhou P; Tian F; Zou J; Shang Z
    Mini Rev Med Chem; 2010 Apr; 10(4):309-14. PubMed ID: 20470246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A knowledge-based halogen bonding scoring function for predicting protein-ligand interactions.
    Liu Y; Xu Z; Yang Z; Chen K; Zhu W
    J Mol Model; 2013 Nov; 19(11):5015-30. PubMed ID: 24072554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Halogen bonding in complexes of proteins and non-natural amino acids.
    Borozan SZ; Stojanović SĐ
    Comput Biol Chem; 2013 Dec; 47():231-9. PubMed ID: 24200696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5-HT
    Fierro A; Matthies DJ; Cassels BK; Jaque P; Zapata-Torres G
    J Chem Inf Model; 2021 Oct; 61(10):5001-5012. PubMed ID: 34617740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tuning the activity of known drugs via the introduction of halogen atoms, a case study of SERT ligands - Fluoxetine and fluvoxamine.
    Staroń J; Pietruś W; Bugno R; Kurczab R; Satała G; Warszycki D; Lenda T; Wantuch A; Hogendorf AS; Hogendorf A; Duszyńska B; Bojarski AJ
    Eur J Med Chem; 2021 Aug; 220():113533. PubMed ID: 34049262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unstable, metastable, or stable halogen bonding interaction involving negatively charged donors? A statistical and computational chemistry study.
    Yang Z; Xu Z; Liu Y; Wang J; Shi J; Chen K; Zhu W
    J Phys Chem B; 2014 Dec; 118(49):14223-33. PubMed ID: 25390886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluating the potential of halogen bonding in molecular design: automated scaffold decoration using the new scoring function XBScore.
    Zimmermann MO; Lange A; Boeckler FM
    J Chem Inf Model; 2015 Mar; 55(3):687-99. PubMed ID: 25654403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.